Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.JAMA|October 21, 2024
Strategies to Help Patients Navigate High Prescription Drug CostsHussain S Lalani, Catherine S Hwang, Aaron S Kesselheim, et al.JAMA Health Forum|March 29, 2024
Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar CompetitionKimberly Feng, Massimiliano Russo, Luca Maini, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 20, 2022
Using Multiple Authorized Generics to Maintain High Prices: The Example of EntacaponeBenjamin N Rome, Alexander C Egilman, Neeraj G Patel, et al.JAMA Network Open|May 4, 2021
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket CostsBenjamin N Rome, William B Feldman, Rishi J Desai, et al.The Oncologist|June 14, 2025
Medicare spending and use of subcutaneous biologic formulations with hyaluronidaseJohn Kim, Aaron S Kesselheim, Edward R Scheffer Cliff, et al.JCO Oncology Practice|November 7, 2025
Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer TreatmentJeddeo M Paul, Aaron P Mitchell, Aaron S Kesselheim, et al.Journal of General Internal Medicine|February 6, 2024
Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-sectional Analysis of Direct-to-Consumer PharmaciesHussain S Lalani, Frazer A Tessema, Aaron S Kesselheim, et al.The Patient|February 8, 2022
Qualitative Research Informing a Preference Study on Selecting Cannabis for Cancer Survivor Symptom Management: Design of a Discrete Choice ExperimentColene Bentley, Sara Izadi-Najafabadi, Adam Raymakers, et al.The Milbank Quarterly|March 22, 2021
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing RegulationVÉronique C Raimond, William B Feldman, Benjamin N Rome, et al.Pageof 11